Unjha Formulations reports Profit after tax of Rs -0.62 Mln, in the March 2022 quarter

02 May 2022 Evaluate
The sales moved up 36.22% to Rs. 42.95 millions for the March 2022 quarter as compared to Rs. 31.53 millions during the year-ago period.The Net Loss for the quarter ended March 2022 is Rs. -0.62 millions as compared to Net Loss of Rs. -2.55 millions of corresponding quarter ended March 2021 Operating profit Margin for the quarter ended March 2022 improved to 1.22% as compared to -0.73% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 42.95 31.53 36.22 143.51 101.72 41.08 143.51 101.72 41.08
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 1.22 -0.73 -267.12 5.09 3.58 42.18 5.09 3.58 42.18
Interest 1.19 1.62 -26.54 1.32 1.73 -23.70 1.32 1.73 -23.70
PBDT 0.03 -2.35 -101.28 3.77 1.85 103.78 3.77 1.85 103.78
Depreciation 0.18 0.20 -10.00 0.76 0.81 -6.17 0.76 0.81 -6.17
PBT -0.15 -2.55 -94.12 3.01 1.04 189.42 3.01 1.04 189.42
TAX 0.47 0.00 0.00 0.47 0.00 0.00 0.47 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.62 -2.55 -75.69 2.54 1.04 144.23 2.54 1.04 144.23
Equity 44.81 44.81 0.00 44.81 44.81 0.00 44.81 44.81 0.00
PBIDTM(%) 2.84 -2.32 -222.68 3.55 3.52 0.78 3.55 3.52 0.78

Unjha Formulations Share Price

30.00 -1.31 (-4.18%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.